Spacer length and serum protein adsorption affect active targeting of trastuzumab-modified nanoparticles.

Barth C., Spreen H., Mulac D., Keuter L., Behrens M., Humpf H.-U., Langer K.

Research article (journal) | Peer reviewed

Details about the publication

JournalBiomaterials and Biosystems (Biomater Biosyst)
Volume5
Page range100032null
StatusPublished
Release year2022
Language in which the publication is writtenEnglish
DOI10.1016/j.bbiosy.2021.100032
KeywordsNanoparticles; Human serum albumin; Polyethylene glycol; Trastuzumab; Active targeting; Protein corona; Human serum; Proteomics

Authors from the University of Münster

Barth, Christina
Professorship of Pharmaceutical Technology and Biopharmacy (Prof. Langer)
Behrens, Matthias
Institute of Food Chemistry
Humpf, Hans-Ulrich
Professur für Lebensmittelchemie (Prof. Humpf)
Keuter, Lucas
Professur für Lebensmittelchemie (Prof. Humpf)
Langer, Klaus
Professorship of Pharmaceutical Technology and Biopharmacy (Prof. Langer)
Mulac-Hahnen, Dennis
Professorship of Pharmaceutical Technology and Biopharmacy (Prof. Langer)
Spreen, Hendrik
Professorship of Pharmaceutical Technology and Biopharmacy (Prof. Langer)